• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B群链球菌(无乳链球菌)VI型荚膜多糖的免疫化学及毒力特性

Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci).

作者信息

von Hunolstein C, D'Ascenzi S, Wagner B, Jelínková J, Alfarone G, Recchia S, Wagner M, Orefici G

机构信息

Laboratory of Bacteriology and Medical Mycology, Istituto Superiore di Sanità, Rome, Italy.

出版信息

Infect Immun. 1993 Apr;61(4):1272-80. doi: 10.1128/iai.61.4.1272-1280.1993.

DOI:10.1128/iai.61.4.1272-1280.1993
PMID:8454331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC281358/
Abstract

The immunochemistry of capsular type polysaccharide and virulence characteristics of group B streptococci (GBS), type VI, were studied. By high-pressure anion-exchange chromatography and pulsed amperometric detection, as well as by 13C nuclear magnetic resonance analysis, both extracellular and cell-bound polysaccharides were found to contain glucose, galactose, and N-acetylneuraminic acid in the molar ratio of 2:2:1, respectively. At variance with all other GBS serotypes described to date (Ia, Ib, II, III, IV, and V), no N-acetylglucosamine was present, whatever the source of the material (secreted or cell bound; reference or clinical isolate). Sialic acid was probably involved in the immunodeterminant structure of this new serotype since cleavage of this sugar from the polysaccharide gave rise to an antigen which reacted very weakly with type VI antiserum and to a precipitation line in immunodiffusion with no identity with the native type VI polysaccharide. By using type VI antiserum and the protein A-gold technique, a large capsule was observed in the type VI GBS reference strain by electron microscopy. All type VI strains examined were lethal for CD-1 mice, the 50% lethal dose after intraperitoneal challenge ranging from 1.0 (+/- 0.9, standard deviation) x 10(5) to 2.5 (+/- 1.5, standard deviation) x 10(5) CFU per mouse. A rabbit antiserum against capsular type polysaccharide exhibited both protective activity for mice injected intraperitoneally with type VI reference strain or with clinical isolates and opsonic activity in a phagocytosis assay.

摘要

对B族链球菌(GBS)VI型的荚膜多糖免疫化学和毒力特性进行了研究。通过高压阴离子交换色谱和脉冲安培检测,以及13C核磁共振分析,发现细胞外多糖和细胞结合多糖均分别含有摩尔比为2:2:1的葡萄糖、半乳糖和N-乙酰神经氨酸。与迄今描述的所有其他GBS血清型(Ia、Ib、II、III、IV和V)不同,无论材料来源如何(分泌型或细胞结合型;参考菌株或临床分离株),均不存在N-乙酰葡糖胺。唾液酸可能参与了这种新血清型的免疫决定簇结构,因为从多糖中裂解这种糖会产生一种与VI型抗血清反应非常弱的抗原,并且在免疫扩散中产生一条与天然VI型多糖无同一性的沉淀线。通过使用VI型抗血清和蛋白A-金技术,电子显微镜观察到VI型GBS参考菌株中有一个大的荚膜。所有检测的VI型菌株对CD-1小鼠均具有致死性,腹腔注射后的50%致死剂量为每只小鼠1.0(±0.9,标准差)×105至2.5(±1.5,标准差)×105 CFU。针对荚膜多糖的兔抗血清对腹腔注射VI型参考菌株或临床分离株的小鼠具有保护活性,并且在吞噬试验中具有调理活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae7c/281358/d12cb707babd/iai00016-0119-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae7c/281358/42596941b3e5/iai00016-0118-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae7c/281358/d12cb707babd/iai00016-0119-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae7c/281358/42596941b3e5/iai00016-0118-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae7c/281358/d12cb707babd/iai00016-0119-a.jpg

相似文献

1
Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci).B群链球菌(无乳链球菌)VI型荚膜多糖的免疫化学及毒力特性
Infect Immun. 1993 Apr;61(4):1272-80. doi: 10.1128/iai.61.4.1272-1280.1993.
2
Virulence properties of type VII Streptococcus agalactiae (group B streptococci) and immunochemical analysis of capsular type polysaccharide.VII型无乳链球菌(B族链球菌)的毒力特性及荚膜型多糖的免疫化学分析
J Med Microbiol. 1999 Nov;48(11):983-990. doi: 10.1099/00222615-48-11-983.
3
Isolation and characterization of type IV group B Streptococcus capsular polysaccharide.B族链球菌IV型荚膜多糖的分离与鉴定
Infect Immun. 1989 Apr;57(4):1089-94. doi: 10.1128/iai.57.4.1089-1094.1989.
4
Structural and immunochemical characterization of the type VIII group B Streptococcus capsular polysaccharide.B族链球菌VIII型荚膜多糖的结构与免疫化学特性
J Biol Chem. 1996 Apr 12;271(15):8786-90. doi: 10.1074/jbc.271.15.8786.
5
Structural elucidation of the novel type VII group B Streptococcus capsular polysaccharide by high resolution NMR spectroscopy.通过高分辨率核磁共振光谱法对新型VII型B族链球菌荚膜多糖进行结构解析。
Carbohydr Res. 1995 Nov 7;277(1):1-9. doi: 10.1016/0008-6215(95)00195-y.
6
Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine.I a型多糖-破伤风类毒素结合疫苗对I a型和I b型B族链球菌保护性抗体的刺激作用。
Infect Immun. 1993 Nov;61(11):4760-6. doi: 10.1128/iai.61.11.4760-4766.1993.
7
Role of group B streptococcal capsular polysaccharides in the induction of septic arthritis.B族链球菌荚膜多糖在感染性关节炎诱导中的作用。
J Med Microbiol. 1998 Aug;47(8):717-23. doi: 10.1099/00222615-47-8-717.
8
L-ficolin and capsular polysaccharide-specific IgG in cord serum contribute synergistically to opsonophagocytic killing of serotype III and V group B streptococci.脐血清中的 L-岩藻糖结合蛋白和荚膜多糖特异性 IgG 协同作用,促进对 III 型和 V 型 B 群链球菌的调理吞噬杀伤作用。
Infect Immun. 2012 Jun;80(6):2053-60. doi: 10.1128/IAI.06232-11. Epub 2012 Mar 26.
9
Fisher scientific award lecture - the capsular polysaccharides of Group B Streptococcus and Streptococcus suis differently modulate bacterial interactions with dendritic cells.费希尔科学奖演讲——B 群链球菌和猪链球菌荚膜多糖不同调节细菌与树突状细胞的相互作用。
Can J Microbiol. 2012 Mar;58(3):249-60. doi: 10.1139/w2012-003. Epub 2012 Feb 22.
10
Identification of Group B Streptococcus Capsule Type by Use of a Dual Phenotypic/Genotypic Assay.使用双表型/基因型检测法鉴定B族链球菌荚膜类型
J Clin Microbiol. 2017 Sep;55(9):2637-2650. doi: 10.1128/JCM.00300-17. Epub 2017 Jun 14.

引用本文的文献

1
Virulence and pathogenicity of group B : Virulence factors and their roles in perinatal infection.B族链球菌的毒力与致病性:毒力因子及其在围产期感染中的作用
Virulence. 2025 Dec;16(1):2451173. doi: 10.1080/21505594.2025.2451173. Epub 2025 Jan 23.
2
Structure of the type IX group B Streptococcus capsular polysaccharide and its evolutionary relationship with types V and VII.B群链球菌IX型荚膜多糖的结构及其与V型和VII型的进化关系。
J Biol Chem. 2014 Aug 22;289(34):23437-48. doi: 10.1074/jbc.M114.567974. Epub 2014 Jul 2.
3
L-Ficolin/mannose-binding lectin-associated serine protease complexes bind to group B streptococci primarily through N-acetylneuraminic acid of capsular polysaccharide and activate the complement pathway.

本文引用的文献

1
A SEROLOGICAL DIFFERENTIATION OF SPECIFIC TYPES OF BOVINE HEMOLYTIC STREPTOCOCCI (GROUP B).牛溶血性链球菌(B 群)的血清学分型鉴别。
J Exp Med. 1934 Mar 31;59(4):441-58. doi: 10.1084/jem.59.4.441.
2
The thiobarbituric acid assay of sialic acids.唾液酸的硫代巴比妥酸测定法。
J Biol Chem. 1959 Aug;234(8):1971-5.
3
Diffusion-in-gel methods for immunological analysis.用于免疫分析的凝胶扩散法。
L-纤维胶凝蛋白/甘露糖结合凝集素相关丝氨酸蛋白酶复合物主要通过荚膜多糖的N-乙酰神经氨酸与B族链球菌结合,并激活补体途径。
Infect Immun. 2008 Jan;76(1):179-88. doi: 10.1128/IAI.00837-07. Epub 2007 Oct 15.
4
Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytes.B族链球菌荚膜唾液酸与人白细胞上的唾液酸结合免疫球蛋白样凝集素(siglecs)相互作用。
J Bacteriol. 2007 Feb;189(4):1231-7. doi: 10.1128/JB.01155-06. Epub 2006 Sep 22.
5
Structural and genetic diversity of group B streptococcus capsular polysaccharides.B族链球菌荚膜多糖的结构与遗传多样性
Infect Immun. 2005 May;73(5):3096-103. doi: 10.1128/IAI.73.5.3096-3103.2005.
6
Immunization with C5a peptidase or peptidase-type III polysaccharide conjugate vaccines enhances clearance of group B Streptococci from lungs of infected mice.用C5a肽酶或肽酶III型多糖结合疫苗进行免疫可增强感染小鼠肺部B族链球菌的清除。
Infect Immun. 2002 Nov;70(11):6409-15. doi: 10.1128/IAI.70.11.6409-6415.2002.
7
Genotyping of the capsule gene cluster (cps) in nontypeable group B streptococci reveals two major cps allelic variants of serotypes III and VII.不可分型B族链球菌中荚膜基因簇(cps)的基因分型揭示了血清型III和VII的两种主要cps等位基因变体。
J Clin Microbiol. 2000 Sep;38(9):3420-8. doi: 10.1128/JCM.38.9.3420-3428.2000.
8
The serotype of type Ia and III group B streptococci is determined by the polymerase gene within the polycistronic capsule operon.Ia型和B族链球菌III型的血清型由多顺反子荚膜操纵子内的聚合酶基因决定。
J Bacteriol. 2000 Aug;182(16):4466-77. doi: 10.1128/JB.182.16.4466-4477.2000.
9
Molecular characterization of type-specific capsular polysaccharide biosynthesis genes of Streptococcus agalactiae type Ia.无乳链球菌Ia型特异性荚膜多糖生物合成基因的分子特征分析
J Bacteriol. 1999 Sep;181(17):5176-84. doi: 10.1128/JB.181.17.5176-5184.1999.
10
Soluble antigens from group B streptococci induce cytokine production in human blood cultures.B族链球菌的可溶性抗原可在人血培养物中诱导细胞因子产生。
Infect Immun. 1997 Oct;65(10):4017-21. doi: 10.1128/iai.65.10.4017-4021.1997.
Prog Allergy. 1958;5:1-78.
4
Phagocytic and bactericidal activity of human neutrophils against two isolates of Group B streptococci Type Ic of differing pathogenicity.人类中性粒细胞对两株致病性不同的Ic型B族链球菌的吞噬和杀菌活性。
Br J Exp Pathol. 1981 Aug;62(4):393-7.
5
Effects of route and time of administration of antiserum on protection of mice from lethal infection due to group B Streptococcus type III.抗血清给药途径和时间对小鼠抵御Ⅲ型B族链球菌致死性感染的保护作用。
Infect Immun. 1981 Jan;31(1):391-5. doi: 10.1128/iai.31.1.391-395.1981.
6
The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus.特异性抗体在B族链球菌III型替代补体途径介导的调理吞噬作用中的作用
J Exp Med. 1980 May 1;151(5):1275-87. doi: 10.1084/jem.151.5.1275.
7
Structure of native polysaccharide antigens of type Ia and type Ib group B Streptococcus.Ia型和Ib型B族链球菌天然多糖抗原的结构
Biochemistry. 1983 Mar 1;22(5):1258-64. doi: 10.1021/bi00274a042.
8
Structural and conformational analysis of sialyloligosaccharides using carbon-13 nuclear magnetic resonance spectroscopy.
Biochemistry. 1984 Jul 31;23(16):3754-9. doi: 10.1021/bi00311a029.
9
Assessment of the virulence factors of group B streptococci: correlation with sialic acid content.B族链球菌毒力因子的评估:与唾液酸含量的相关性
J Infect Dis. 1983 May;147(5):857-63. doi: 10.1093/infdis/147.5.857.
10
Structural determination of the capsular polysaccharide antigen of type II group B Streptococcus.
J Biol Chem. 1983 Feb 10;258(3):1793-8.